Abstract
It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Current Cancer Therapy Reviews
Title:The Adrenergic System in Gastrointestinal Cancers
Volume: 8 Issue: 2
Author(s): Zhi Jie Li and Chi Hin Cho
Affiliation:
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Abstract: It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Export Options
About this article
Cite this article as:
Jie Li Zhi and Hin Cho Chi, The Adrenergic System in Gastrointestinal Cancers, Current Cancer Therapy Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339412800675379
DOI https://dx.doi.org/10.2174/157339412800675379 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Current Cardiology Reviews Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians
Current Medicinal Chemistry Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Sodium-Iodide Symporter
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Efficacy of Chemopreventive Agents in Mouse Mammary Gland Organ Culture (MMOC) Model: A Comprehensive Review
Current Medicinal Chemistry The Role of LEF/TCF Factors in Neoplastic Transformation
Current Molecular Medicine Trends and Prospects of Plant Proteases in Therapeutics
Current Medicinal Chemistry The Role of TNFSF15 in the Modulation of Neovascularization and Inflammation
Current Hypertension Reviews The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Regeneration of Pancreatic β-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders
Reviews on Recent Clinical Trials Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design 6-Chloro-7-methyl-3', 4'-dimethoxyflavone – a Potent Selective COX-2 Inhibitor
Medicinal Chemistry Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer
Current Pharmaceutical Design PDGF-D Signaling: A Novel Target in Cancer Therapy
Current Drug Targets